Wells Fargo’s Sutro Biopharma STRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$495 Sell
693
-48,441
-99% -$34.6K ﹤0.01% 5912
2025
Q1
$32K Sell
49,134
-3,604
-7% -$2.35K ﹤0.01% 5091
2024
Q4
$97K Buy
52,738
+10,466
+25% +$19.3K ﹤0.01% 4728
2024
Q3
$146K Buy
42,272
+415
+1% +$1.44K ﹤0.01% 4390
2024
Q2
$123K Buy
41,857
+14,490
+53% +$42.5K ﹤0.01% 4453
2024
Q1
$155K Buy
27,367
+4,194
+18% +$23.7K ﹤0.01% 4264
2023
Q4
$99.4K Buy
23,173
+3,656
+19% +$15.7K ﹤0.01% 4497
2023
Q3
$67.7K Sell
19,517
-8,058
-29% -$28K ﹤0.01% 4672
2023
Q2
$128K Sell
27,575
-22,588
-45% -$105K ﹤0.01% 4616
2023
Q1
$232K Buy
50,163
+44,473
+782% +$205K ﹤0.01% 4078
2022
Q4
$46K Buy
5,690
+4,372
+332% +$35.3K ﹤0.01% 4597
2022
Q3
$8K Sell
1,318
-1,434
-52% -$8.7K ﹤0.01% 5451
2022
Q2
$14K Sell
2,752
-35,357
-93% -$180K ﹤0.01% 5327
2022
Q1
$313K Sell
38,109
-14,108
-27% -$116K ﹤0.01% 4433
2021
Q4
$777K Sell
52,217
-60,603
-54% -$902K ﹤0.01% 4047
2021
Q3
$2.13M Sell
112,820
-27,349
-20% -$517K ﹤0.01% 3441
2021
Q2
$2.61M Sell
140,169
-3,566
-2% -$66.3K ﹤0.01% 3287
2021
Q1
$3.27M Buy
143,735
+80,989
+129% +$1.84M ﹤0.01% 3093
2020
Q4
$1.36M Buy
62,746
+17,059
+37% +$370K ﹤0.01% 3735
2020
Q3
$459K Buy
45,687
+15,012
+49% +$151K ﹤0.01% 4297
2020
Q2
$238K Buy
30,675
+9,213
+43% +$71.5K ﹤0.01% 4652
2020
Q1
$218K Buy
21,462
+2,041
+11% +$20.7K ﹤0.01% 4464
2019
Q4
$213K Buy
19,421
+5,486
+39% +$60.2K ﹤0.01% 4764
2019
Q3
$127K Buy
13,935
+2,451
+21% +$22.3K ﹤0.01% 4990
2019
Q2
$130K Buy
11,484
+8,113
+241% +$91.8K ﹤0.01% 4979
2019
Q1
$38K Buy
3,371
+71
+2% +$800 ﹤0.01% 5289
2018
Q4
$30K Buy
+3,300
New +$30K ﹤0.01% 5354